Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$963M |
| 3 |
Wells Fargo
WFC
|
+$647M |
| 4 |
ConocoPhillips
COP
|
+$632M |
| 5 |
UnitedHealth
UNH
|
+$490M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$907M |
| 3 |
KKR & Co
KKR
|
+$906M |
| 4 |
CRH
CRH
|
+$670M |
| 5 |
Meta Platforms (Facebook)
META
|
+$593M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.49% |
| 2 | Technology | 10.44% |
| 3 | Healthcare | 8.01% |
| 4 | Financials | 6.79% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OLO
2726
DELISTED
Olo Inc
OLO
| $4.4M | ﹤0.01% |
996,486
+194,735
| +24% | +$922K |
|
2727
CALL
Madrigal Pharmaceuticals
MDGL
$12.3B
| $4.4M | ﹤0.01% |
15,700
+14,800
| +1,644% | +$3.52M |
|
2728
Ethan Allen Interiors
ETD
$597M
| $4.39M | ﹤0.01% |
157,480
+150,409
| +2,127% | +$4.46M |
|
2729
Adicet Bio
ACET
$84.8M
| $4.38M | ﹤0.01% |
226,354
-30,282
| -12% | -$811K |
|
2730
Oportun Financial
OPRT
$338M
| $4.37M | ﹤0.01% |
1,507,012
+314,553
| +26% | +$954K |
|
2731
Matthews International
MATW
$653M
| $4.36M | ﹤0.01% |
174,192
-11,188
| -6% | -$307K |
|
2732
Smith & Wesson
SWBI
$573M
| $4.35M | ﹤0.01% |
+303,648
| New | +$4.99M |
|
2733
Cricut
CRCT
$1.21B
| $4.35M | ﹤0.01% |
725,612
-428,990
| -37% | -$2.57M |
|
2734
CALL
Jacobs Solutions
J
$17.8B
| $4.34M | ﹤0.01% |
37,599
+17,167
| +84% | +$2.01M |
|
|
NOA
2735
North American Construction
NOA
$353M
| $4.34M | ﹤0.01% |
225,336
+159,142
| +240% | +$3.31M |
|
2736
Gorman-Rupp
GRC
$2.01B
| $4.34M | ﹤0.01% |
118,284
-88,186
| -43% | -$3.11M |
|
2737
PUT
Zimmer Biomet
ZBH
$19.2B
| $4.34M | ﹤0.01% |
40,000
+29,400
| +277% | +$3.47M |
|
2738
PUT
Raymond James Financial
RJF
$34.5B
| $4.34M | ﹤0.01% |
35,100
+28,000
| +394% | +$3.46M |
|
2739
PUT
Charles River Laboratories
CRL
$13.9B
| $4.34M | ﹤0.01% |
21,000
-63,700
| -75% | -$14.4M |
|
2740
Ibotta
IBTA
$747M
| $4.33M | ﹤0.01% |
+57,671
| New | +$5.37M |
|
2741
PUT
Sarepta Therapeutics
SRPT
$2.2B
| $4.33M | ﹤0.01% |
27,400
+7,900
| +41% | +$1.01M |
|
2742
Inspire Medical Systems
INSP
$1.78B
| $4.33M | ﹤0.01% |
32,326
+18,236
| +129% | +$3.45M |
|
2743
Supernus Pharmaceuticals
SUPN
$2.54B
| $4.32M | ﹤0.01% |
161,332
+128,743
| +395% | +$3.73M |
|
2744
Navient
NAVI
$887M
| $4.3M | ﹤0.01% |
295,592
+193,451
| +189% | +$2.99M |
|
2745
Standex International
SXI
$3.62B
| $4.3M | ﹤0.01% |
+26,676
| New | +$4.51M |
|
2746
Inhibrx
INBX
$1.82B
| $4.3M | ﹤0.01% |
+303,196
| New | +$4.74M |
|
2747
NatWest
NWG
$73B
| $4.3M | ﹤0.01% |
535,016
-103,097
| -16% | -$800K |
|
2748
LegalZoom.com
LZ
$1.05B
| $4.28M | ﹤0.01% |
509,748
+43,039
| +9% | +$443K |
|
|
KDK
2749
Kodiak AI
KDK
$782M
| $4.27M | ﹤0.01% |
400,000
| – | – |
|
2750
WesBanco
WSBC
$3.88B
| $4.27M | ﹤0.01% |
152,858
+125,883
| +467% | +$3.48M |
|
Similar funds
Israel Englander's Q2 2024 Portfolio in Review
As of Q2 2024, Israel Englander held 6,803 positions worth $216B, down 7.8% from $234B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Israel Englander's Q2 2024 filing shows 661 new, 2,109 increased, 2,549 reduced and 995 closed positions. Its largest new stake was QXO Inc: 2,219,158 shares worth $20.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $963M.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2024 buy was QXO Inc: 2,219,158 shares worth $20.6M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $1.12B increase.
- Israel Englander's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $963M.
- Israel Englander fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $907M.
- Israel Englander's ten largest holdings make up 16% of its $216B portfolio in Q2 2024.
- Israel Englander opened 661 new positions and closed 995 in Q2 2024.
- Israel Englander's portfolio value fell 7.8% quarter-over-quarter to $216B.
Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.